共 25 条
[11]
Mamolo MG, 1996, FARMACO, V51, P71
[12]
MAZZONE G, 1993, FARMACO, V48, P1207
[13]
MILS J, 1977, MOL CRYST LIQCRYST, V303, P14
[14]
MIYAMOTO K, 1985, CHEM PHARM BULL, V33, P5216
[15]
DESIGN OF 5-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)-1,3,4-THIADIAZOLES, 5-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)-1,3,4-OXADIAZOLES, AND 5-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)-1,2,4-TRIAZOLES AS ORALLY-ACTIVE, NONULCEROGENIC ANTIINFLAMMATORY AGENTS
[J].
JOURNAL OF MEDICINAL CHEMISTRY,
1993, 36 (08)
:1090-1099
[18]
Sheldrick G.M., 1997, SHELXS97 PROGRAM SOL
[19]
Sheldrick G.M., 1997, Crystal Structure Refinement
[20]
SHELDRICK GM, 1997, SADABS PROGRAM ABSOR